Abstract��
To research the protective effects of Acanthus ilicifolius alkaloids A and its two derivatives in the rats with immune hepatic fibrosis. METHODS Immune hepatic fibrosis model was established by intraperitoneal administration porcine serum. SD rats were treated intragastric administration with , , (3-acetyl-4-acetoxy-2-benzoxazolone,TC-3). The activities of ALT, AST in serum and the levels of HA and LN in serum were measured. RESULTS Compared with the normal control group, the activities of ALT,AST and the levels of HA and LN in the model group were significantly increased. Compared with the model group, animals treated with the HBOA, AcO-BOA or TC-3 could decrease the activities of ALT and AST and the levels of HA and LN markedly. Histopathological results showed that treatment groups could relieve the porcine serum-induced liver damage. CONCLUSION HBOA and its derivatives have protective effect on the rats with immune-mediated hepatic fibrosis.
ZHOU Li-Juan,
CAI Li-Ping,
CHEN Xiao-Ying etc
.Protective Effects of Acanthus ilicifolius Alkaloids A and Its Derivatives on Immune Hepatic Fibrosis in Rats[J] Chinese Pharmaceutical Journal, 2013,V48(20): 1744-1747
��
[1]
BARTUS R T,DEAN III L D,BEER B,et al. The cholinergic hypothesis of geriatric memory dysfunction . Science,1982,217(30):408-417.[2] GLENNER G G,WONG C E. Alzheimer��s disease and Down��s syndrome: Sharing of a unique cerebrovascular amyloid fibril protein . Biochem Biophys Res Co,1984,122(3): 1131-1135.[3] G LENNER G G,WONG C E. Alzheimer��s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein . Biochem Biophys Res Co,1984,120(3): 885-890.[4] SCARPINI E,SCHELTENS P,FELDMAN H. Treatment of Alzheimer��s disease: current status and new perspectives . Lancet Neurol,2003,2(9): 539-547.[5] MA Z Y,HE Y,ZHAO W G,et al. Design,synthesis and in vitro antifungal activity of 3-substituted-methylenechroman-4-ones . Acta Pharm Sin(ҩѧѧ��),2012,47(5): 614-618.[6] BULZOMI P,BOLLI A,GALLUZZO P,et al. Naringenin and 17��- estradiol coadministration prevents hormone-induced human cancer cell growth . IUBMB Life,2010,62(5): 51-60.[7] LIHY,ZHANG L L,ZHANG C M,et al. Synthesis and anti-platelet aggregative activity of the Mannich bases of 4-chromanones and 4-chromones . Fine Chem Intermediates (��ϸ�����м���),2008,38(1):13-17.[8] RONG S,XIAO L,JING Z. Design synthesis and evaluation of flavonoid derivatives as poten AChE inhibitors . Bioorgan Med Chem J,2009,17(18): 6692-6698.[9] CHEN L,FANG L,FANG X B,et al.The new target of acetylcholinesterase inhibitors against Alzheimer��s disease research progress. Chin Pharm J (�й�ҩѧ��־),2010,45(21): 1606-1611. GAN L L,CAI J L,ZHOU C H. Recent researches in piperazine-containing compounds sa receptor ligands.Chin Pharm J(�й�ҩѧ��־),2009,44(18): 1361-1368. ELLMAN G L,COURTNEY K D,ANDRES V,et al. A new and rapid colorimetric determination of acetylcholinesterase activity . Biochem Pharmacol,1961(7): 88-95. MA Z Y,YAN G Y,YANG G L,et al. Synthesis and antifungal activities in vitro of 2,3,3a,4-tetrahydrothiochromenopyrazole derivatives . Chin Pharm J (�й�ҩѧ��־),2009,44(8): 630-633.
[2]
Electroencephalogram and Epilepsy Chapter of Chinese Society of Neurology. Expert consensus opinion in treatment of epilepsy. Chin J Neurol(�л�����־), 2011, 44(5): 56-65.[2] BEGHI E, MESSINAA P, PUPILLO E, et al. Satisfaction with antiepileptic drugs in children and adolescents with newly diagnosed and chronic epilepsy . Epilepsy Res, 2012, 100(1): 142-151.[3] ETTINGER A B, MANJUNATH R, CANDRILLI S D, et al. Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy . Epilepsy Behav, 2009, 14(2): 324-329.[4] Chinese Medical Association. Guidelines of Clinical Diagnosis and Therapy��Epilepsy Fascicule (�ٴ�����ָ�ϡ������ֲ�). 2nd ed. Beijing: People��s Medical Publishing House, 2008.[5] ALIBHAI S M H, HAN R K, NAGLIE G. Medication education of acutely hospitalized older patients . J Gen Intern Med, 1999, 14: 610-616.[6] SUPERIOR C K, BROYLES J E, OLIPHANT C S, et al. Development and evaluation of a medication education videotape for hospitalized patients. Am J Health Syst Pharm, 2002, 59(9): 859-861.[7] PATEL A M, TOROK K S, ROSEN P. Improvement in medication education in a pediatric subspecialty practice . PediatrRheumatol Online J, 2010, 8: 25-29.[8] ROTER D L, HALL J A, MERISCA R, et al. Effectiveness of interventions to improve patient compliance: A meta-analysis . Medical Care, 1998, 36(8): 1138-1161.[9] VAN DULMEN S, SLUIJS E, VAN DIJK L, et al. Patient adherence to medical treatment: A review of reviews . Bmc Health Serv Res, 2007, 7(1): 55-67. American Society of Health-system Pharmacists. ASHP guidelines on pharmacist-conducted patient education and counseling . Am J Health-Syst Pharm, 1997, 54: 431-434. American Society of Health-system Pharmacists. ASHP guidelines on the provision of medication information . Am J Health-Syst Pharm, 1996, 53: 1843-1845. LIU L L, YIU C H, YEN D J, et al. Medication education for patients with epilepsy in Taiwan . Seizure, 2003, 12(7): 473-477. ZHEN H Q, WANG G C. The contents and methods of patient education . China Licensed Pharmacist(�й�ִҵҩʦ), 2008, 5(12): 34. QI X L, ZHENG N W, JIA D, et al. Comparative study of medication education on patients with oral administration of antiepileptic drugs . Chin Pharm J(�й�ҩѧ��־), 2006, 41(8): 637-639. LI J, LV Q Z. Practice and analysis of warfarin on patient medication counseling and medication education . Chin Pharm J(�й�ҩѧ��־), 2008, 43(14): 1113-1115.
[3]
CEVC G, BLUME G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta,1992, 1104(1): 226�C232. MISHRA D, GARG M, DUBEY V, et al. Elastic liposomes mediated transdermal delivery of an antihypertensive agent: Propranolol hydrochloride. J Pharm Sci, 2007, 96(1): 145-155. CHEN J, LIN A H, CHEN Z P, et al. Ammonium sulfate gradient loading of brucine into liposomes: Effect of phospholipid composition on entrapment effiency and physicochemical properties in vitro. Drug Dev Ind Pharm, 2010, 36(3): 245-253. SCOGNAMIGLIO I, STEFANO D D, CAMPANI V, et al. Nanocarriers for topical administration of resveratrol: A comparative study . Int J Pharm, 2013,440(2):179-187.
[4]
BABU B H, SHYLESH B S, PADIKKALA J. Antioxidant and hepatoprotective effect of Acanthus ilicifolius. Fitoterapia,2001, 72(3):272-277.[2] GANESH S, VENNILA J J. Screening for Antimicrobial Activity in Acanthus ilicifolius. Arch Appl Sci Res, 2010, 2(5):311-315.[3] BABU B H, SHYLESH B S, PADIKKALA J. Tumour reducing and anticarcinogenic activity of Acanthus ilicifolius in mice. J Ethnopharmacol,2002, 79(1):27-33.[4] GULCAN H O, KUPELI E, UNLU S, et al. 4-(5-chloro-2(3H)-benzoxazolon-3-yl)butanoic acid derivatives: Synthesis, antinociceptive and anti-inflammatory properties. Arch Pharm,2003, 336(10):477-482.[5] GU X H, FANG D C. Regulation of hepatic stellate cell activation and proliferation and collagen synthesis by protease activated receptors and Role of protease receptors in liver fibrosis . World Chin J Digestol(���绪��������־),2006,19(5):502-507.[6] SUN N, GAO S X. Progress in mechanism, animals model and therapy of hepatic fibrosis. Chin J Pharm Anal(ҩ�������־),2007,27(3):470-475.[7] LIU H, WEI W, SUN W Y, et al. Protective effects of astragaloside IV on porcine-serum-induced hepatic fibrosis in rats and in vitro effects on hepatic stellate cells. J Ethnopharmacol, 2009, 122(3):502-508. [8] PARSIAN H, RAHIMIPOUR A, NOURI M, et al. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis. J Gastrointestin Liver Dis, 2010, 19(2):169-174.[9] ZHANG Y, DU G L, CHEN D X, et al. Dynamic observation of immune liver fibrosis in rats induced by porcine serum. Chin J Integr Trad West Med Dig(�й�����ҽ���������־), 2007, 15(2):74-77. HAO R C, MEN J Z, LI X B, et al. Effects of Xiongshao Decotion on immune liver fibrosis in rats. Chin Tradit Herb Drug(�в�ҩ),2012,43(1):115-118. KHIN E E, QI P, FAN H, et al. The protective effect against acute liver injury in mice by 4-acetoxy-2-benzoxalone. Lishizhen Med Mat Med Res(ʱ���ҽ��ҩ),2012,23(5):1088-1089. QI P, FAN H, LIANG Y E, et al. Protective effect of 4-Hydroxy-2-benzoxazolone against acute liver injury in mice. Lishizhen Med Mat Med Res (ʱ���ҽ��ҩ), 2012,23(7):1668-1669. LU S Y, PI P, LIANG Y E, et al. Protective effect of 3-acetyl-4- acetoxy-2-benzoxazolone against acute liver injury in mice by cardon tetrachloride. Chin Pharm J(�й�ҩѧ��־), 2012, 47(22): 1813-1815.
2013, Vol. 48 
